Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Tatiana Segura
University of California Los Angeles, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
Tempo Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Professor Segura will train and mentor Dr. Griffin in biological assays and vascular biology. She is a founder and advisor for the company.
VEGF Gradients in Porous Hydrogels for Therapeutic Angiogenesis
Angiogenesis is critical to wound repair. A comprehensive study of the relationship between 3D gradients of VEGF (a potent stimulator of endothelial growth and chemotaxis) and endothelial tip cell activation would expand scientific knowledge and potentially assist in improving clinical treatment of wound sites, especially for individuals with diminished healing capabilities (e.g. diabetics).
Filed on January 28, 2016.
Tell us what you know about Tatiana Segura's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Tatiana Segura”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Tatiana Segura | Duke University | Conflict of Interest | Tempo Therapeutics, Inc. | $0 - $4,999 |
| Tatiana Segura | Duke University | Conflict of Interest | Tempo Therapeutics, Inc. | Value cannot be readily determined |
| Tatiana Segura | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics, Inc. | $0 - $4,999 |
| Tatiana Segura | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics, Inc. | Value cannot be readily determined |
| Tatiana Segura | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics | Value cannot be readily determined |
| Tatiana Segura | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics | Value cannot be readily determined |
| Tatiana Segura | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics | $60,000 - $79,999 |
| Tatiana Segura | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics | $0 - $4,999 |
| Tatiana Segura | University of California Los Angeles | Conflict of Interest | Tempo Therapeutics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.